AJP - Endocrinology and Metabolism, Vol 257, Issue 1 E35-E42, Copyright © 1989 by American Physiological Society

ARTICLES

Contribution of cortisol to glucose counterregulation in humans

P. De Feo, G. Perriello, E. Torlone, M. M. Ventura, C. Fanelli, F. Santeusanio, P. Brunetti, J. E. Gerich and G. B. Bolli
Istituto di Patologia Medica, Universita di Perugia, Italy.

To test the hypothesis that cortisol secretion plays a counterregulatory role in hypoglycemia in humans, four studies were performed in eight normal subjects. In all studies, insulin (15 mU.m-2.min-1) was infused subcutaneously (plasma insulin 27 +/- 1 microU/ml). In study 1, plasma glucose concentration and glucose fluxes [( 3-3H]glucose), substrate, and counterregulatory hormone concentrations were simply monitored, and plasma glucose decreased from 89 +/- 2 to 52 +/- 2 mg/dl for 12 h. In study 2, (pituitary-adrenal-pancreatic clamp), insulin and counterregulatory hormone secretion (except for catecholamines) was prevented by somatostatin (0.5 mg/h, iv) and metyrapone (0.5 g/4 h, per os), and glucagon, cortisol, and growth hormone were infused to reproduce the concentrations of study 1. In study 3 (lack of cortisol increase), the pituitary-adrenal-pancreatic clamp was performed with maintenance of plasma cortisol at basal levels, and glucose was infused, whenever needed, to reproduce plasma glucose concentration of study 2. Study 4 was identical to study 3, but exogenous glucose was not infused. Isolated lack of cortisol increase caused a approximately 22% decrease in hepatic glucose production (P less than 0.01) and a approximately 15% increase in peripheral glucose utilization (P less than 0.01), which resulted in greater hypoglycemia (37 +/- 2 vs. 52 +/- 2 mg/dl, P less than 0.01) despite compensatory increases in plasma epinephrine. Lack of cortisol response also reduced plasma free fatty acid, beta-hydroxybutyrate, and glycerol concentrations approximately 50%. We conclude that cortisol normally plays an important counterregulatory role during hypoglycemia by augmenting glucose production, decreasing glucose utilization, and accelerating lipolysis.

This article has been cited by other articles:

				L. Jacobson, T. Ansari, J. Potts, and O. P. McGuinness Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E15 - E22. [Abstract] [Full Text] [PDF]

				P. Lucidi, G. Murdolo, C. Di Loreto, A. De Cicco, N. Parlanti, C. Fanelli, F. Santeusanio, G. B. Bolli, and P. De Feo Ghrelin Is Not Necessary for Adequate Hormonal Counterregulation of Insulin-Induced Hypoglycemia Diabetes, October 1, 2002; 51(10): 2911 - 2914. [Abstract] [Full Text] [PDF]

				A. Battezzati, A. Caumo, A. Fattorini, L. P. Sereni, J. Coppa, R. Romito, M. Ammatuna, E. Regalia, V. Mazzaferro, and L. Luzi Amino Acid Kinetics During the Anhepatic Phase of Liver Transplantation Diabetes, June 1, 2002; 51(6): 1690 - 1698. [Abstract] [Full Text] [PDF]

				K. Hojlund, M. Wildner-Christensen, O. Eshoj, C. Skjarbak, J. J. Holst, O. Koldkjar, D. Moller Jensen, and H. Beck-Nielsen Reference intervals for glucose, {beta}-cell polypeptides, and counterregulatory factors during prolonged fasting Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E50 - E58. [Abstract] [Full Text] [PDF]

				M. Mevorach, J. Kaplan, C. J. Chang, L. Rossetti, and H. Shamoon Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E421 - E429. [Abstract] [Full Text] [PDF]

				P. Del Corral, E. T. Howley, M. Hartsell, M. Ashraf, and M. S. Younger Metabolic effects of low cortisol during exercise in humans J Appl Physiol, March 1, 1998; 84(3): 939 - 947. [Abstract] [Full Text] [PDF]

				F.J. Service Hypoglycemic Disorders N. Engl. J. Med., April 27, 1995; 332(17): 1144 - 1152. [Full Text] [PDF]